5Holgate ST,Holloway J,Wilson S,et al.Epithelial-mesenchymalcommunication in the pathogenesis of chronic asthma[J].TheAmerican Thoracic Society,2004,1(2):93-98.
6Bodil,Malin,Agnes E.Non-tuberculous mycobacteria and theirsurface lipids efficiently induced IL-17 production in human Tcells[J].Microbes and infection/Institut Pasteur,2012,13(14):1186-1195.
7Openshaw PJ, Dean GS, Culley FJ. Links between respira- tory syncytial virus bronchiolitis and childhood asthma: clini- cal and research approaches [J]. Pediatr Infect Dis J,2003,22(2 Suppl): $58-$64.
8Black CP. Systematic review of the biology and medical mana- gement of respiratory syncytial virus infection [J]. Respir Care, 2003,48(3): 209-23l.
9Stensballe LG, Devasundaram JK, Simoes EA. Respiratory syncytial virus epidemics:the ups and downs of a seasonal virus [J]. Pediatr Infect Dis J, 2003,22(2 Suppl): $21-$32.
10Jafri HS, Chavez-Bueno S, Mejias A, et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice [J]. J Infect Dis, 2004,189(10): 1856-1865.
